To provide compounds which have high angiogenesis inhibiting activity, and are useful as agents for effective treatment and prevention of diseases involving pathologic angiogenesis, for example, cancer and cancer metastasis, methods for producing the compounds, intermediate compounds useful for their production, and pharmaceutical compositions containing these compounds.The present invention provides compounds of formula (II), or prodrugs thereof, or pharmaceutically acceptable salts of the compounds or the prodrugs, and pharmaceuticals, and pharmaceutical compositions containing these compounds: where A1 is C—X1 or N; Q1 is —A2═A3—, or a heteroatom selected from —O—, —S—, and —N(R10)—; Q2 is —A4═A5—, or a heteroatom selected from —O—, —S—, and —N(R10)—; provided that Q1 and Q2 are not heteroatoms at the same time; A2 is C—X2 or N, A3 is C—X3 or N, A4 is C—X4 or N, and A5 is C—X5 or N; Y is C1-6alkyl, C3-9cycloalkyl, C2-7alkenyl, C2-7alkynyl, C1-6alkoxy, C2-7alkenyloxy, C2-7alkynyloxy, or C1-6alkylthio; Z is a hydrogen atom, hydroxy, C1-6alkyl, C3-9cycloalkyl, or —NR1R2; and L is selected from the formula: